Skip to main content
. 2022 Feb 1;61(11):e202115695. doi: 10.1002/anie.202115695

Figure 1.

Figure 1

Identification of the main therapeutic targets that would inhibit SARS‐CoV‐2 entry. Image was created using BioRender.com.